Use of a blood test in the monitoring of ovarian cancer patients who are in remission is an example of the “fatal attraction of more information” in medicine, according to an editorial published July 21 in JAMA Oncology.
The … Read more
When Sherry Pollex was diagnosed with stage three ovarian cancer at age 35, one doctor suggested she wouldn’t live more than a couple of years. But two years later, after beating that prognosis, she celebrated by launching SherryStrong.org — a … Read more
Medical science is more advanced than at any point in history. Yet the health care system — medical science applied to actual patients — still leaves many people without the best and latest treatments.
For example, new knowledge about health … Read more
Buried in the fine print of many marketplace health plan documents is language that allows them to refuse to cover a range of services that are used more often by women, a study finds. It’s unclear if these exclusions have … Read more
With a unique approach that draws on 3-D printing technologies, a team of University of Wisconsin-Madison researchers is developing new tools for understanding how ovarian cancer develops in women.About 1.5 percent of American women will be diagnosed with ovarian cancer, … Read more
A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy (NACT) is the optimal first-line treatment for some women who have newly diagnosed advanced ovarian … Read more
Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals, provide new research routes for scientists trying to detect … Read more
Commentary about ‘The Improvisational Oncologist’ written by The Clearity Foundation’s founder, Dr. Laura Shawver:
Dr. Mukhergee’s article, ‘The Improvisational Oncologist’, in the New York Times Magazine hits our mission at The Clearity Foundation front and center. He remarks that, “every … Read more
By: Annette McElhiney
Nemesis is defined as, “the inescapable agent of someone’s or something’s downfall.” This word seems perfect to characterize neuropathy as for many people with post chemo neuropathy, the condition literally causes us to take numerous, unwanted falls.… Read more
Government scientists are seeking a million volunteers willing to share the innermost secrets of their genes and daily lives as part of an ambitious 10-year research project to understand the causes and cures of disease.
Those selected to be members … Read more
The University of California, San Francisco announced last week that the California Initiative to Advance Precision Medicine (CIAPM) will provide $7.2 million in new funding to support to new precision medicine research projects.
The CIAPM was established in 2015 with … Read more
Simplifying the way ovarian patients are tested is a “win-win” that saves both lives and money, a study shows. Testing their DNA should identify the most effective drugs and finds out if other family members are at risk.
Fewer than … Read more
By: Annette McElhiney
Nearly everyone has heard the term Precision Medicine. However most of us have only a shallow understanding of what precision medicine means. To fully understand, go to the government web site and read the President’s initiative in … Read more
Over the past 20 years, Nazneen Rahman has identified a steady stream of genes that influence the risk of breast, ovarian, and childhood cancers—work that has earned her scientific, popular, and even royal acclaim. But her latest accomplishment, and one … Read more
Promising new therapies are springing up to treat ovarian cancer, long one of the most deadly and hard to treat malignancies. The latest: An experimental drug from Tesaro, a small biotech company based in Waltham, Mass. The company on Wednesday … Read more
With the number of cancer survivors growing every day, the question of what to eat after a cancer diagnosis is quickly becoming a hot topic. Some survivors believe it is of little importance: they have already been through cancer, so … Read more
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more
By: Annette McElhiney
“Resilience presents a challenge for psychologists. Whether you can be said to have it or not largely depends not on any particular psychological test but on the way your life unfolds. If you are lucky enough to … Read more
Lack of exercise is associated with an increased risk of ovarian cancer and of death from the disease, two new studies suggest. “Women may be overwhelmed with mixed messages about physical activity or exercise recommendations and opt to be inactive
… Read moreYou’ve probably heard the adage that you are more likely to regret the things you didn’t do than the things you did. Maybe there’s a long lost love that got away, a career you wish you had pursued, a trip
… Read more
